Bristol-Myers (BMY) Agrees to Buy Amylin Pharma (AMLN) for USD5.3 Billion - 0 views
-
macy macon on 02 Jul 12"Bristol-Myers Squibb Co has agreed to acquire Amylin Pharmaceuticals Inc, a maker of diabetes therapies at a total cost of $5.3 billion as it is desperately trying to replace revenue that it is losing from the declining sales of its blood thinner that is facing generic competition."